Press release
Pulmonary Arterial Hypertension Treatment Market Analysis, Growth Opportunity and Forecast, 2026
Pulmonary Arterial Hypertension Treatment Market
Change in routine of consumers in terms of lack of physical activity and more consumption of alcohol, tobacco, and fast food products increases the chances of developing hypertension and high blood pressure. The increased blood pressure in turn, gives rise to several diseases such as stroke and heart attacks. Treatment of pulmonary arterial hypertension can be done by using drugs such as endothelin receptor antagonists, prostacyclin and prostacyclin analogs, soluble guanylate cyclase stimulators, and phosphodiesterase type 5 inhibitor.
๐๐จ๐ฐ๐ง๐ฅ๐จ๐๐ ๐๐๐ ๐๐จ๐ฎ๐๐ก๐๐ซ: https://www.alliedmarketresearch.com/request-sample/5470
The pulmonary arterial hypertension treatment market is segmented based on the drug type, sales channel, and region. Under the drug type segment, the market is classified into endothelin receptor antagonists ERAs, prostacyclin & prostacyclin analogs, sGC stimulators, and PDE-5 dipsticks. Endothelin receptor antagonists are further divided into bosentan, ambrisentan, and macitentan. Prostacyclin analogs are further categorized into epoprostenol, iloprost, and treprostinil. sGC stimulators include riociguat. PDE-5 dipsticks are further divided into sildenafil and tadalafil. Based on sales channel, market is studied across hospital pharmacy, retail pharmacy, and online pharmacy. Based on region, the pulmonary arterial hypertension market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
๐๐ฎ๐ซ๐๐ก๐๐ฌ๐ ๐๐ง๐ช๐ฎ๐ข๐ซ๐ฒ: https://www.alliedmarketresearch.com/purchase-enquiry/5470
Increase in launch of innovative drugs & treatment therapies, favorable initiatives such as rare disease act and orphan drug act by government, rise in prevalence of pulmonary arterial hypertension disease, increase in consumption of alcohol or tobacco, sedentary lifestyle, smoking, & other idiopathic conditions, increase in geriatric population, and increase in adoption of treatment & healthcare spending are the factors that drive the growth of the pulmonary arterial hypertension market.
๐๐๐ฒ ๐๐๐ง๐๐๐ข๐ญ๐ฌ:
โข This report provides a detailed quantitative analysis of the current market trends and market forecast estimations from 2019 to 2026, which assists to identify the prevailing pulmonary arterial hypertension treatment market opportunities.
โข An in-depth market analysis includes analysis of various regions and is anticipated to provide a detailed understanding of the current trends to enable stakeholders formulate region-specific plans.
โข A comprehensive analysis of the factors that drive and restrain the growth of the global market is provided.
โข Region-wise and country-wise market conditions are comprehensively analyzed in this report.
โข The projections in this report are made by analyzing the current market trends and future market potential from 2019 to 2026 in terms of value.
โข An extensive analysis of various regions provides insights that are expected to allow companies to strategically plan their business moves.
โข Key market players within the market are profiled in this report and their strategies are analyzed thoroughly, which helps understand competitive outlook of the global pulmonary arterial hypertension treatment market.
๐๐๐ช๐ฎ๐๐ฌ๐ญ ๐๐ฎ๐ฌ๐ญ๐จ๐ฆ๐ข๐ณ๐๐ญ๐ข๐จ๐ง: https://www.alliedmarketresearch.com/request-for-customization/5470
Some of major players operating in the pulmonary arterial hypertension treatment market include United Therapeutic Corporation, Eli Lilly and Company, Actelion Inc., GlaxoSmithKline plc. (GSK), Steady Med Ltd., Gilead Sciences, Inc., Pfizer Inc., Teva Pharmaceuticals Inc., Actelion Pharmaceuticals, Ltd., Novartis International AG, and Bayer AG.
๐๐ญ๐ก๐๐ซ ๐๐ซ๐๐ง๐๐ข๐ง๐ ๐๐๐ฉ๐จ๐ซ๐ญ๐ฌ:
Surgical Robotic System Market: https://www.alliedmarketresearch.com/surgical-robotic-systems-market-A06827
Healthcare Interoperability Solutions Market: https://www.alliedmarketresearch.com/healthcare-interoperability-solutions-market-A07075
Surgical Drains Market: https://www.alliedmarketresearch.com/wound-drainage-surgical-drains-market-A07517
Contact Us:
David Correa
5933 NE Win Sivers Drive
205, Portland, OR 97220
United States
Toll Free: 1-800-792-5285
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1-855-550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com
๐๐๐จ๐ฎ๐ญ ๐๐ฌ:
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP, based in Portland, Oregon. AMR provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
AMR introduces its online premium subscription-based library Avenue, designed specifically to offer cost-effective, one-stop solution for enterprises, investors, and universities. With Avenue, subscribers can avail an entire repository of reports on more than 2,000 niche industries and more than 12,000 company profiles. Moreover, users can get an online access to quantitative and qualitative data in PDF and Excel formats along with analyst support, customization, and updated versions of reports.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Pulmonary Arterial Hypertension Treatment Market Analysis, Growth Opportunity and Forecast, 2026 here
News-ID: 2600636 • Views: โฆ
More Releases from Allied Analytics LLP
Heat Meters Market Set to Grow with Rising Demand for Energy Efficiency
According to a new report published by Allied Market Research, the heat meters market size was valued at $1.6 billion in 2022, and is estimated to reach $2.7 billion by 2032, growing at a CAGR of 5.4% from 2023 to 2032.
A heat meter is a device used to measure and quantify the amount of thermal energy (heat) transferred from a heat source to a system or consumer. It accurately measuresโฆ
Heat Pump Market Set for Strong Growth Through 2032
According to a new report published by Allied Market Research, the heat pump market size was valued at $71.2 billion in 2022, and is estimated to reach $201.5 billion by 2032, growing at a CAGR of 11.1% from 2023 to 2032.
A heat pump is a versatile and efficient device that transfers heat from one location to another using a refrigeration cycle. It operates by absorbing heat from a low-temperature sourceโฆ
Energy Efficient Lighting Market Shines Bright with Strong Growth Outlook
According to a new report published by Allied Market Research, the global energy efficient lighting market was valued at $46.2 billion in 2021 and is projected to reach $93.3 billion by 2030, growing at a robust CAGR of 8.1% from 2022 to 2030. This surge reflects a powerful global movement toward greener, smarter, and more cost-effective lighting technologies.
Energy efficient lighting refers to lighting systems and products that use less electricityโฆ
The Future of Energy: How Fuel Cells Are Reshaping Power Generation
According to a new report published by Allied Market Research, titled, "Fuel Cell Market," The fuel cell market size was valued at $3.6 billion in 2020, and is estimated to reach $32.0 billion by 2030, growing at a CAGR of 19.4% from 2021 to 2030.
The fuel cell market has emerged as a transformative force in the global energy landscape, offering a clean, efficient, and sustainable alternative to conventional energy sources.โฆ
More Releases for Pulmonary
Chronic Pulmonary Aspergillosis Drugs Market - Revitalizing Lungs: Revolutionary โฆ
Newark, New Castle, USA - new report, titled Chronic Pulmonary Aspergillosis Drugs Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Chronic Pulmonary Aspergillosis Drugs market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Chronic Pulmonary Aspergillosis Drugs market. The report offersโฆ
Global Pulmonary Embolism Market Size & Trends
According to a new market research report published by Global Market Estimates, the Global Pulmonary Embolism Market is exhibited at USD 1.59 billion in 2023 and is projected to surpass USD 3.15 billion in 2028, anticipated to grow at a CAGR of 8.4% from 2023 to 2028.
The rapid increase in the prevalence of cancer, increasing investment for healthcare infrastructure and rising research and development activities, high disposable income, rising demandโฆ
Global Pulmonary Arterial Hypertension Market Size
According to a new market research report published by Global Market Estimates, the Global Pulmonary Arterial Hypertension Market is projected to grow at a CAGR of 5.2% from 2022 to 2027.
Congenital heart diseases and other ailments such as HIV infection, chronic liver disease (cirrhosis), and connective tissue disorders (scleroderma, lupus, and others) are fueling market expansion.
Browse 153 Market Data Tables and 113 Figures spread through 185 Pages and in-depth TOCโฆ
New Study: Pulmonary Drugs Market Report
The pulmonary drugs market is expected to witness unprecedented growth in the near future, thanks to large number of approvals from the FDA. The FDA approved a large number of pulmonary drugs for major illnesses like small-cell lung cancer, tuberculosis, and pneumonia over the past few years. Additionally, newly approved drugs also treat newly found diseases like obstructive sleep apnea. These approvals are in line with the recent trend ofโฆ
Pulmonary Drugs Market Forecast till 2025
Pulmonary Drugs Market โ Boon for Diseased Lungs
Pulmonary drugs can treat wide range of conditions, which are included within the ambit of pulmonary diseases such as pneumonia, allergic rhinitis, pulmonary hypertension, and others. . Pulmonary drugs provide medications for all types of pulmonary diseases, which is expected to fuel market growth in near future. The World Health Organization (WHO) states that most respiratory diseases are preventable and can be treatedโฆ
Pulmonary Drug Delivery Devices Market: Demand for Pulmonary Drug Delivery Devic โฆ
This report on pulmonary drug delivery devices studies the current as well as future prospects of the market globally. The stakeholders of this report include companies and intermediaries engaged in the manufacture and commercialization of various pulmonary/respiratory drugs and/or drug-device combinations as well as new entrants planning to enter this market.
This report comprises an elaborate executive summary along with a market snapshot providing overall information of various segments and sub-segmentsโฆ
